The FDA is rapidly deploying artificial intelligence across its operations in an ambitious effort to transform drug review processes. This government-wide push toward AI integration showcases both the potential efficiency gains and inherent risks of implementing generative AI in highly regulated environments where scientific accuracy is paramount and errors could have significant public health implications.
The big picture: The FDA has announced immediate implementation of AI tools across all centers following a generative AI pilot program for scientific reviewers, with full agency-wide integration mandated by June 30.
- The agency is promoting the technology as a way to accelerate drug reviews by automating repetitive scientific tasks that previously required days of manual work.
- This aggressive timeline for deploying AI across the entire agency raises questions about appropriate testing, validation, and safeguards against AI hallucinations in critical scientific review processes.
What they’re saying: FDA officials are touting dramatic efficiency improvements from their initial AI implementation experience.
- “This is a game-changer technology that has enabled me to perform scientific review tasks in minutes that used to take three days,” said Jinzhong Liu, a deputy director in the FDA’s Center for Drug Evaluation and Research.
- FDA commissioner Martin Makary has directed all FDA centers to achieve “full AI integration” with a “common, secure generative AI system integrated with FDA’s internal data platforms” by the end of June.
Behind the scenes: The FDA’s AI initiative appears to have connections to private sector AI developers and government efficiency advocates.
- According to Wired reporting, representatives from OpenAI met multiple times with FDA officials and associates from Elon Musk‘s “Department of Government Efficiency” regarding a project called “cderGPT.”
- The FDA’s official announcement notably omits any mention of OpenAI’s involvement, despite these reported meetings.
Why this matters: The FDA’s rapid AI adoption represents one of the most significant deployments of generative AI in federal regulatory science, potentially establishing precedents for how AI tools are implemented in high-stakes government decision-making processes.
Recent Stories
DOE fusion roadmap targets 2030s commercial deployment as AI drives $9B investment
The Department of Energy has released a new roadmap targeting commercial-scale fusion power deployment by the mid-2030s, though the plan lacks specific funding commitments and relies on scientific breakthroughs that have eluded researchers for decades. The strategy emphasizes public-private partnerships and positions AI as both a research tool and motivation for developing fusion energy to meet data centers' growing electricity demands. The big picture: The DOE's roadmap aims to "deliver the public infrastructure that supports the fusion private sector scale up in the 2030s," but acknowledges it cannot commit to specific funding levels and remains subject to Congressional appropriations. Why...
Oct 17, 2025Tying it all together: Credo’s purple cables power the $4B AI data center boom
Credo, a Silicon Valley semiconductor company specializing in data center cables and chips, has seen its stock price more than double this year to $143.61, following a 245% surge in 2024. The company's signature purple cables, which cost between $300-$500 each, have become essential infrastructure for AI data centers, positioning Credo to capitalize on the trillion-dollar AI infrastructure expansion as hyperscalers like Amazon, Microsoft, and Elon Musk's xAI rapidly build out massive computing facilities. What you should know: Credo's active electrical cables (AECs) are becoming indispensable for connecting the massive GPU clusters required for AI training and inference. The company...
Oct 17, 2025Vatican launches Latin American AI network for human development
The Vatican hosted a two-day conference bringing together 50 global experts to explore how artificial intelligence can advance peace, social justice, and human development. The event launched the Latin American AI Network for Integral Human Development and established principles for ethical AI governance that prioritize human dignity over technological advancement. What you should know: The Pontifical Academy of Social Sciences, the Vatican's research body for social issues, organized the "Digital Rerum Novarum" conference on October 16-17, combining academic research with practical AI applications. Participants included leading experts from MIT, Microsoft, Columbia University, the UN, and major European institutions. The conference...